SECLIPSA
DEAD

Serial Number

85965540

Owner

Celgene Corporation

Attorney

Camille M. Miller

Filing Date

Jun 20, 2013

Add to watchlist:

No watchlists yet
View on USPTO

SECLIPSA Trademark

Serial Number: 85965540 • Registration: 4566690

SECLIPSA is a trademark filed by Celgene Corporation on June 20, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

June 20, 2013

Registration Date

July 15, 2014

Published for Opposition

April 29, 2014

Cancellation Date

February 19, 2021

Goods & Services

pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of oncology, inflammation, dermatology and ophthalmology diseases and illnesses

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 19, 2021 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 15, 2019 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 29, 2015 TCCA
REGISTERED-PRINCIPAL REGISTER
Jul 15, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2014 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 9, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 21, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2014 CRFA
ASSIGNED TO LIE
Mar 17, 2014 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 28, 2014 PARI
EXAMINER'S AMENDMENT ENTERED
Feb 27, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 27, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 27, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 27, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2014 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 2, 2013 GPRN
PRIORITY ACTION E-MAILED
Oct 2, 2013 GPRA
PRIORITY ACTION WRITTEN
Oct 2, 2013 CPRA
ASSIGNED TO EXAMINER
Sep 26, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2013 NWOS
NEW APPLICATION ENTERED
Jun 24, 2013 NWAP